| # | Company | Location | Employees | Total Funding | Last Round | Last Funded |
|---|---|---|---|---|---|---|
| 1 |
enGene
enGene is a biotechnology company develops treatment for mucosal diseases throug…
|
Vancouver | 11 - 50 | $409.6M | Post Ipo Debt | 2026-01-20 |
| 2 |
Beta Bionics
Beta Bionics is a biotechnology company that provides software to reduce the bur…
|
Irvine | 251 - 500 | $353.5M | Series E | 2024-11-13 |
| 3 |
Welldoc
Welldoc is a digital health platform that helps in managing chronic conditions.
|
Columbia | 101 - 250 | $55.2M | Series B | 2016-03-01 |
| 4 |
Dexcom
Dexcom develops, manufactures, and distributes continuous glucose monitoring sys…
|
San Diego | c 10001 max | $2.2B | Post Ipo Debt | 2023-05-02 |
| 5 |
Podimetrics
Podimetrics is a care management company with the leading solution to help preve…
|
Somerville | 101 - 250 | $98.2M | Debt Financing | 2022-11-22 |
| 6 |
Glooko
Glooko as a digital health company that offers a diabetes management platform to…
|
Palo Alto | 101 - 250 | $301.0M | Series F | 2024-10-10 |
| 7 |
Bigfoot Biomedical
Bigfoot Biomedical is a medical device company changing diabetes care for people…
|
Milpitas | 51 - 100 | $204.6M | Convertible Note | 2022-08-15 |
| 8 |
HabitNu
Our HabitNu program provides support-based diabetes management.
|
Chicago | 11 - 50 | $14.6M | Grant | 2024-03-07 |
| 9 |
Eyenuk
Eyenuk is a medtech company that develops an artificial intelligence screening t…
|
Woodland Hills | 11 - 50 | $47.4M | Series A | 2022-10-17 |
| 10 |
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes an…
|
San Diego | 1K - 5K | $641.5M | Post Ipo Debt | 2024-03-06 |
| 11 |
Olakino
Olakino is an exercise app that helps people suffering from diabetes to exercise…
|
Helsinki | 1 - 10 | $612K | Convertible Note | 2024-09-03 |
| 12 |
Sugar.fit
Sugar.fit is a healthtech startup that helps users manage and reverse diabetes.
|
Bengaluru | 251 - 500 | $25.9M | Series A | 2024-03-13 |
| 13 |
Journeys Metabolic
Journeys Metabolic is an interoperable metabolic digital therapeutic platform th…
|
St Louis | 11 - 50 | $3.1M | Seed | 2023-02-22 |
| 14 |
KalVista Pharmaceuticals
KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs…
|
Cambridge | 251 - 500 | $821.8M | Post Ipo Debt | 2025-09-24 |
| 15 |
Cecelia Health
Cecelia Health is a health-tech company that connects clinical coaching and prop…
|
New York | 51 - 100 | $22.4M | Series B | 2020-08-13 |
| 16 |
BeatO
BeatO is a developer of a health monitoring application that helps diabetic pati…
|
New Delhi | 251 - 500 | $47.4M | Series B | 2022-11-16 |
| 17 |
G.I. Windows
G.I. Windows is a clinical-stage company developing the first fundamental breakt…
|
Westwood | 11 - 50 | $94.4M | Series B | 2024-11-20 |
| 18 |
Hedia
Hedia is a personal diabetes-assistant, based on artificial intelligence.
|
Copenhagen | 11 - 50 | $11.7M | Seed | 2024-02-23 |
| 19 |
Una Health
The most effective Digital Therapy to reverse metabolic dysfunction based on mob…
|
Berlin | 1 - 10 | $2.5M | Seed | 2024-02-15 |
| 20 |
Intuity Medical
Intuity Medical develops blood glucose monitoring systems for diabetes managemen…
|
Fremont | 51 - 100 | $365.2M | Debt Financing | 2021-01-01 |
| 21 |
Health2Sync
Health2Sync develops systems that transform smartphones into legacy medical devi…
|
Tokyo | 11 - 50 | $30.5M | Series C | 2025-03-05 |
| 22 |
AgaMatrix
AgaMatrix develops and manufactures a line of diabetes products designed to impr…
|
Salem | 251 - 500 | $152.2M | Debt Financing | 2019-07-03 |
| 23 |
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to de…
|
Beverly | 51 - 100 | $46.6M | Series H | 2025-04-30 |
| 24 |
DiabetOmics
DiabetOmics is a medical diagnostics company that provides non-invasive assessme…
|
Beaverton | 11 - 50 | $12.1M | Series Unknown | 2018-01-12 |
| 25 |
Sensars
Sensars restores natural foot sensation in diabetics, preventing ulcers and ampu…
|
Lausanne | 1 - 10 | $4.8M | Seed | 2025-09-11 |
| 26 |
Apollon
Apollon develops noninvasive continuous glucose monitoring systems.
|
Cambridge | 11 - 50 | $2.7M | Grant | 2025-11-07 |
| 27 |
Breathe Well-being
Breathe Wellbeing is a health tech startup that helps people manage and prevent …
|
New Delhi | 51 - 100 | $12.8M | Series B | 2023-01-19 |
| 28 |
Scioto Biosciences
Scioto is a developer of Activated Bacterial Therapeutics platform.
|
Indianapolis | 11 - 50 | $31.0M | Series B | 2020-08-10 |
| 29 |
ViaCyte
ViaCyte is a preclinical therapeutic company specializing in regenerative medici…
|
San Diego | 51 - 100 | $235.5M | Series D | 2021-04-22 |
| 30 |
Virta Health
Virta delivers a clinically-proven treatment to reverse type 2 diabetes and othe…
|
San Francisco | 501 - 1K | $373.0M | Series E | 2021-04-19 |
| 31 |
HYGIEIA
Hygieia is a developer of a diabetes insulin guidance system used to enhance and…
|
Ann Arbor | 11 - 50 | $35.3M | Series B | 2023-05-02 |
| 32 |
Indigo Diabetes
Indigo Diabetes is a medtech company that develops a multi-biomarker sensor for …
|
Zwijnaarde | 11 - 50 | $52.0M | Series B | 2020-07-27 |
| 33 |
Fitterfly
Fitterfly offers customized and personalized wellness programs for diabetes care…
|
Mumbai | 251 - 500 | $15.1M | Series A | 2022-07-20 |
| 34 |
Bluedrop Medical
Remote patient monitoring (RPM) for patients at risk of diabetic foot disease.
|
Galway | 11 - 50 | $34.0M | Undisclosed | 2026-02-02 |
| 35 |
Zucara Therapeutics
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hy…
|
Vancouver | 11 - 50 | $53.8M | Series B | 2025-05-01 |
| 36 |
Aerami Therapeutics
Aerami Therapeutics focuses on developing novel inhaled therapies for the treatm…
|
Durham | 11 - 50 | $133.5M | Series B | 2022-09-20 |
| 37 |
Orangebiomed
Orangebiomed is a healthcare startup with cutting-edge diabetes management techn…
|
Seoul | 1 - 10 | $7.6M | Series A | 2025-06-26 |
| 38 |
Metavention
Metavention develops medical devices to help with interventional therapies for h…
|
Eden Prairie | 11 - 50 | $65.0M | Series C | 2018-01-08 |
| 39 |
AMF Medical
AMF Medical is a MedTech company that develops an Insulin Patch Pump.
|
Ecublens | 1 - 10 | $21.0M | Corporate Round | 2022-09-01 |
| 40 |
Zhixin Haozheng
Zhixin Haozheng is an inventor of regenerating islet technology.
|
Suzhou | 11 - 50 | $27.8M | Series A | 2025-05-06 |
| 41 |
Biovotion
Biovotion is a digital health company in the field of sophisticated, medical-gra…
|
Z├╝rich | 11 - 50 | $13.5M | Series A | 2017-07-11 |
| 42 |
Vitadio
Vitadio develops software and online tools to help prevent and control diabetes.
|
Prague | 11 - 50 | $4.8M | Seed | 2023-09-25 |
| 43 |
Cnoga Medical
Cnoga Medical empowers people with easy-to-use, non-invasive medical devices.
|
Caesarea | 11 - 50 | $62.5M | Series Unknown | 2017-03-06 |
| 44 |
Almouneer
Healthcare, Diabetes, Practice Management, Technology
|
Gîza | 51 - 100 | $3.6M | Seed | 2023-10-31 |
| 45 |
Xeris Biopharma
Xeris Biopharma is a pharmaceutical company that develops therapies for patients…
|
Chicago | 251 - 500 | $548.5M | Post Ipo Debt | 2024-03-06 |
| 46 |
Steto
Steto creates diabetes digital therapies and remote patient monitoring solutions…
|
Paris | 1 - 10 | $1.3M | Seed | 2023-11-14 |
| 47 |
BioGenCell
BioGenCell designs cellular therapies that treat blood flow problems in the limb…
|
Netanya | 1 - 10 | $16.0M | Seed | 2022-05-09 |
| 48 |
DreaMed Diabetes
DreaMed Diabetes offers AI solutions and personalized support for optimized insu…
|
Petah Tiqva | 11 - 50 | $13.3M | Series Unknown | 2024-08-19 |
| 49 |
Sava Technology
Sava Technology creates under-skin sensors to monitor glucose, lactate, and keto…
|
London | 51 - 100 | $26.8M | Series A | 2025-07-30 |
| 50 |
Nutrino
Nutrino is a big data, personalized nutrition platform that offers nutritional …
|
Tel Aviv | 11 - 50 | $11.5M | Series A | 2018-04-10 |